TABLE 4.

Demographic variables associated with Elizabethkingia anophelis bacteremia by strains belonging to the specific lineage and other strains in Changhua Christian Hospital^a

Variable	E. anophelis strains of dominant lineage (n = 226)	Other E. anophelis strains (n = 62)	P value
Age	73.4	71.9	0.456
Sex, male, n (%)	135 (59.7)	40 (64.5)	0.495
Duration of admission, median (IQR), days	56 (35.0–84.0)	44 (28.3–106.7)	0.057
Ward, n (%)			0.035
ICU	79 (35.0)	29 (46.8)
RCC	53 (23.5)	6 (9.7)
RCW	46 (20.4)	11 (17.7)
Ward	48 (21.2)	15 (24.2)
OPD	0 (0)	1 (1.6)
Period of admission, n (%)
2005−2010	0 (0)	31 (50.0)	< 0.001
2011−2015	38 (16.8)	19 (30.6)
2016−2020	188 (83.2)	12 (19.4)
Charlson comorbidity index, median (IQR)	3 (2.0–4.0)	3 (2.0–6.0)	0.0939
Comorbidities, n (%)b
Solid-organ tumor	35 (15.9)	15 (24.2)	0.132
Diabetes mellitus	91 (40.3)	28 (45.2)	0.489
Chronic pulmonary disease	41 (18.1)	12 (19.4)	0.827
Chronic kidney disease	73 (32.3)	18 (29.0)	0.624
Hematologic malignancy	8 (3.5)	6 (9.7)	0.047
Dementia	24 (10.6)	12 (19.4)	0.066
Connective tissue disease	8 (3.5)	1 (1.6)	0.441
Chronic liver disease	32 (14.2)	13 (21.0)	0.192
Steroid use	17 (7.5)	4 (6.5)	0.774
Mechanical ventilation	177 (78.3)	29 (46.8)	<0.001
Antimicrobial treatment, n (%)b
No treatment	27 (11.9)	3 (4.8)	0.105
Aminoglycoside	3 (1.3)	2 (3.2)	0.312
Carbapenem	12 (5.3)	4 (6.5)	0.729
Cephalosporin	13 (5.8)	7 (11.3)	0.129
Glycopeptide	34 (15.0)	16 (25.8)	0.048
Fluoroquinolone	24 (10.6)	20 (32.3)	<0.001
Minocycline	37 (16.4)	1 (1.6)	0.002
Penicillinc	20 (8.8)	13 (21.0)	0.008
Trimethoprim/sulfamethoxazole	149 (65.9)	43 (69.4)	0.613
Mortality, n (%)
14-day mortality	75 (33.2)	10 (16.1)	0.009
In hospital mortality	115 (50.9)	20 (32.2)	0.014

^aICU, intensive care unit; RCC, respiratory care center; RCW, respiratory care ward; OPD, outpatient department.

^bMay be multiple.

^cIncludes ampicillin/sulbactam, piperacillin, piperacillin-tazobactam.